High-cost Drugs

The UK plans to boost its spending on expensive cancer drugs by around £160 million ($264 million) over the next two years, increasing its outlay from £200 million a year to £280 million per year, but the government also wants to increase its scrutiny of how well these drugs work for the cost.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.